An investment column recommending Pfizer as a high-value dividend stock for income-focused portfolios.
Tag: pfizer
Pfizer-Innovent Deal Signals New Wave of Western Pharmaceutical Investment in China
Pfizer’s $10.5 billion deal with Innovent Biologics is being watched as a bellwether for multinational pharmaceutical engagement in China’s healthcare market.
Pfizer Inks Up to $10.5 Billion Deal With China’s Innovent in Major Pharma Partnership
Pfizer announced a massive deal with Chinese biotech Innovent Biologics to co-develop and commercialize new cancer therapies.